A US jury has found that one of the world’s most widely-used weedkillers was a “substantial factor” in causing a man’s cancer. Pharmaceutical group Bayer had strongly rejected claims that its glyphosate-based Roundup product was carcinogenic.
But the jury in San Francisco ruled unanimously that it contributed to causing non-Hodgkin’s lymphoma in California resident Edwin Hardeman. The next stage of the trial will consider Bayer’s liability and damages. During this phase, which starts on [March 20], Mr Hardeman’s lawyers are expected to present evidence allegedly showing Bayer’s efforts to influence scientists, regulators and the public about the safety of its products.
[Editor’s note: Read the GLP’s FAQ Is glyphosate (Roundup) dangerous? for a detailed discussion of glyphosate safety.]
“We are confident the evidence in phase two will show that Monsanto’s conduct has been appropriate and the company should not be liable for Mr. Hardeman’s cancer,” [Bayer] said. Bayer continues “to believe firmly that science confirms that glyphosate-based herbicides do not cause cancer.”
Another Roundup trial is scheduled to begin in California state court in Oakland on 28 March, involving a couple who claim Roundup caused their non-Hodgkin’s lymphoma.
Read full, original article: Weedkiller glyphosate a ‘substantial’ cancer factor